Strategic partnerships Lipotype is an established lipidomics service provider with connections to academia, biotech, pharma, and industry users across life sciences, cosmetics, and food. This presents opportunities to expand collaboration through multi-omics and translational research partnerships, joint grant proposals, and sponsored studies.

Expansion targets Recent activity shows Lipotype engaging with biotech and German biotech events and expanding leadership roles. Sales strategies can focus on onboarding mid-size biotech firms and pharma companies seeking high-throughput lipid profiling with low sample requirements and two-week turnaround.

Executive access With Head of Sales and Head of Finance recently appointed, there is an opportunity to engage senior decision makers in pricing, service bundles, and long-term engagement models. Target enterprise-style contracts, retainer-based lipidomics programs, and expanded service scopes.

Technical fit Lipotype’s capability to quantify over 7000 lipids via mass spectrometry at high throughput and low sample input aligns well with drug discovery, neurodegenerative research, and translational studies. Sales can emphasize fast timelines, scalable capacity, and compliance (ISO 13485) to attract regulated environments.

Market positioning As a spin-off from renowned Max-Planck labs, Lipotype carries credibility for collaborations in academia and industry. Leverage this branding to target large research projects, grants, and contract research opportunities where lipidomics is a key differentiator.